Tỷ lệ các gia đình PspA và đảo pilus trong Streptococcus pneumoniae gây nhiễm trùng ở trẻ em trước và sau khi sử dụng vắc-xin conjugate phế cầu toàn dân tại Brazil

Lynch J, Zhanel G (2009) Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 30(2):189–209. https://doi.org/10.1055/s-0029-1202938 Wang H, Naghavi M, Allen C et al (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1 Corrêa RA, José BPS, Malta DC, Passos VMA, França EB, Teixeira RA, Camargos PAM (2017) Carga de doença por infecções do trato respiratório inferior no Brasil, 1990 a 2015: estimativas do estudo Global Burden of Disease 2015. Rev Bras Epidemiol 20(suppl 1):171–181. https://doi.org/10.1590/1980-5497201700050014 Ministério da Saúde (2019) Portal da Saúde, Tabela de casos confirmados, óbitos, incidência e letalidade por tipo de meningite de 2010 a 2018. Publishing Brazilian Ministry of Health. http://portalarquivos2.saude.gov.br/images/pdf/2019/abril/25/tabela-dados-2010-2018-site.pdf. Accessed 29 Apr 2019 Feldman C, Anderson R (2014) Review: current and new generation pneumococcal vaccines. J Inf 69(4):309–325. https://doi.org/10.1016/j.jinf.2014.06.006 Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH (2015) Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev 28(3):871–899. https://doi.org/10.1128/CMR.00024-15 Westerink MA, Schroeder HW Jr, Nahm MH (2012) Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination. Aging Dis 3(1):51–67 Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378(9807):1962–1973. https://doi.org/10.1016/S0140-6736(10)62225-8 Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC (2006) Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 75(1):350–357. https://doi.org/10.1128/IAI.01103-06 Qian J, Yao K, Xue L, Xie G, Zheng Y, Wang C, Shang Y, Wang H, Wan L, Liu L, Li C, Ji W, Wang Y, Xu P, Yu S, Tang Y-W, Yang Y (2012) Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children. Eur J Clin Microbiol Infect Dis 31(3):217–223. https://doi.org/10.1007/s10096-011-1296-9 Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, Facciotti C, Muzzi A, Giusti F, Emolo C, Sinisi A, Hilleringmann M, Pansegrau W, Censini S, Rappuoli R, Covacci A, Masignani V, Barocchi MA (2008) A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol 190(15):5480–5492. https://doi.org/10.1128/JB.00384-08 Hollingshead SK, Becker R, Briles DE (2000) Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68(10):5889–5900. https://doi.org/10.1128/iai.68.10.5889-5900.2000 Daniels CC, Coan P, King J, Hale J, Benton KA, Briles DE, Hollingshead SK (2010) The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis. Infect Immun 78(5):2163–2172. https://doi.org/10.1128/IAI.01199-09 Schachern PA, Tsuprun V, Goetz S, Cureoglu S, Juhn SK, Briles DE, Paparella MM, Ferrieri P (2013) Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear. JAMA Otolaryngol Head Neck Surg 139(9):937–943. https://doi.org/10.1001/jamaoto.2013.4104 Neves FPG, Pinto TC, Corrêa MA, Barreto RA, Moreira LSG, Rodrigues HG, Cardoso CA, Barros RR, Teixeira LM (2013) Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine. BMC Infect Dis 13(1):318–324. https://doi.org/10.1186/1471-2334-13-318 Neves FPG, Cardoso NT, Snyder RE, Marlow MA, Cardoso CAA, Teixeira LM, Riley LW (2017) Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C. Vaccine. 35(21):2794–2800. https://doi.org/10.1016/j.vaccine.2017.04.019 Rodrigues HG, Pinto TCA, Barros RR, Teixeira LM, Neves FPG (2017) Pneumococcal nasopharyngeal carriage among children in Brazil prior to the introduction of the 10-valent conjugate vaccine: a culture- and PCR-based survey. Epidemiol Infect 145(8):1720–1726. https://doi.org/10.1017/S0950268817000449 Swiatlo E, Brooks-Walter A, Briles DE, McDaniel LS (1997) Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae. Gene 188(2):279–284. https://doi.org/10.1016/s0378-1119(96)00823-2 Vela Coral MC, Fonseca N, Castañeda E, Di Fabio JL, Hollingshead SK, Briles DE (2001) Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children. Emerg Infect Dis 7(5):832–836. https://doi.org/10.3201/eid0705.017510 Hollingshead SK, Baril L, Ferro S, King J, Coan P, Briles DE, Pneumococcal Proteins Epi Study Group (2006) Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries. J Med Microbiol 55(2):215–221. https://doi.org/10.1099/jmm.0.46268-0 Basset A, Trzcinski K, Hermos C, O’Brien KL, Reid R, Santosham M, McAdam AJ, Lipsitch M, Malley R (2007) Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol 45(6):1684–1689. https://doi.org/10.1128/JCM.00265-07 Zähner D, Gudlavalleti A, Stephens DS (2010) Increase in pilus islet 2-encoded pili among Streptococcus pneumoniae isolates, Atlanta, Georgia, USA. Emerg Infect Dis 16(6):955–962. https://doi.org/10.3201/eid1606.091820 Pimenta FC, Dias FR, Brandileone MCC, Miyaji EN, Leite LCC, Andrade ALSS (2006) Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil. J Clin Microbiol 44(8):2838–2843. https://doi.org/10.1128/JCM.00156-06 Khan F, Khan MA, Ahmed N, Khan MI, Bashir H, Tahir S, Zafar AU (2018) Molecular characterization of pneumococcal surface protein A (PspA), serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains isolated from Pakistan. Infect Dis Ther 7(2):277–289. https://doi.org/10.1007/s40121-018-0195-0 Brandileone M-CC, Zanella RC, Almeida SCG, Brandao AP, Ribeiro AF, Carvalhanas T-RMP, Sato H, Andrade A-L, Verani JR (2016) Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil. Vaccine 34(46):5604–5611. https://doi.org/10.1016/j.vaccine.2016.09.027 Organização Panamericana de Saúde (OPAS) (2016) Informe regional de SIREVA II, 2014: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos bacterianos. Publishing OPAS. http://iris.paho.org/xmlui/handle/123456789/33875. Accessed 23 Jul 2019. Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU (2011) The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29(41):7207–7211. https://doi.org/10.1016/j.vaccine.2011.06.056 Kawaguchiya M, Urushibara N, Aung MS, Morimoto S, Ito M, Kudo K, Sumi A, Kobayashi N (2015) Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan. New Microbe New Infect 9:66–72. https://doi.org/10.1016/j.nmni.2015.11.001 Brandileone MCC, Andrade ALSS, Teles EM, Zanella RC, Yara TI, Di Fabio JL (2004) Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines. Vaccine 22(29-30):3890–3896. https://doi.org/10.1016/j.vaccine.2004.04.009 Horácio NA, Silva-Costa C, Diamantino-Miranda J, Lopes JP, Ramirez M, Melo-Cristino J, Portuguese Group for the Study of Streptococcal Infections (2016) Population structure of Streptococcus pneumoniae causing invasive disease in adults in Portugal before PCV13 availability for adults: 2008-2011. PLoS One 11(5):e0153602. https://doi.org/10.1371/journal.pone.0153602 Cassiolato AP, Almeida SCG, Andrade AL, Minamisava R, Brandileone MCC (2018) Expansion of the clonal multidrug-resistant complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil. PLoS One 13(11):e0208211. https://doi.org/10.1371/journal.pone.0208211 Cho EY, Kang HM, Lee J, Kang JH, Choi EH, Lee HJ (2012) Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-Valent conjugate vaccine. J Korean Med Sci 27(7):716–722. https://doi.org/10.3346/jkms.2012.27.7.716 Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14(3):e197–e209. https://doi.org/10.1016/j.ijid.2009.05.010 Moschioni M, De Angelis G, Melchiorre S, Masignani V, Leibovitz E, Barocchi MA, Dagan R (2010) Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clin Microbiol Infect 16(9):1501–1504. https://doi.org/10.1111/j.1469-0691.2009.03105.x